ENTA vs INTU · rev $65.3M vs P/E 64, rev $18.83B
Enanta Pharmaceuticals Inc (ENTA) versus Intuit Inc (INTU) — a side-by-side from cached financials, not a winner call.
Enanta Pharmaceuticals Inc (ENTA) is a biotechnology company listed on US.
Intuit Inc (INTU) is a software - application company listed on US.
Latest reported ENTA revenue for 2025-09-30 was $65.3M. Net income was -$81.9M. ENTA currently screens at market cap $328.0M.
Latest reported INTU revenue for 2025-07-31 was $18.83B. Net income was $3.87B. INTU currently screens at market cap $217.76B and trailing P/E 63.7.
ENTA currently screens at market cap $328.0M. INTU currently screens at market cap $217.76B and trailing P/E 63.7.
Not investment advice. Open the ENTA and INTU stock pages for the full models.
Not investment advice.